Bernier-Latmani Jeremiah, Petrova Tatiana V
Department of Fundamental Oncology, Ludwig Cancer Research, Lausanne Branch, and Institute of Pathology, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Epalinges, Switzerland.
Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, Swiss Federal Institute of Technology Lausanne (EPFL), Lausanne, Switzerland.
J Clin Invest. 2017 Oct 2;127(10):3594-3597. doi: 10.1172/JCI96840. Epub 2017 Sep 18.
Glaucoma is a leading cause of blindness, with an estimated world-wide prevalence of 3.5% in members of the population older than 40 years of age. Elevated intraocular pressure as the result of abnormal resistance to aqueous humor drainage is a major contributing, and the only preventable, factor in glaucoma development. Schlemm's canal (SC), a lymphatic-like vessel encircling the anterior portion of the eye, plays a key role in promoting aqueous humor outflow and maintenance of normal intraocular pressure. The risk of developing glaucoma increases with age; therefore, understanding mechanisms of SC maintenance and how aging affects SC function are of special importance, both for prevention and novel treatment approaches to glaucoma. Using a compelling array of genetic models, Kim et al. report in this issue of the JCI that continuous angiopoietin/TIE2 signaling is required for maintaining SC identity and integrity during adulthood and show that its age-related changes can be rescued by a TIE2 agonistic antibody.
青光眼是导致失明的主要原因,据估计,在40岁以上人群中,全球患病率为3.5%。由于房水引流阻力异常导致的眼压升高是青光眼发展的一个主要促成因素,也是唯一可预防的因素。施莱姆管(SC)是一种环绕眼球前部的淋巴管样血管,在促进房水流出和维持正常眼压方面起关键作用。患青光眼的风险会随着年龄增长而增加;因此,了解施莱姆管维持机制以及衰老如何影响施莱姆管功能,对于青光眼的预防和新治疗方法都具有特别重要的意义。金等人利用一系列令人信服的基因模型在本期《临床研究杂志》上报告称,持续的血管生成素/TIE2信号传导是成年期维持施莱姆管特性和完整性所必需的,并表明其与年龄相关的变化可通过TIE2激动抗体得到挽救。